Established chemical synthesis, process scaling up, pharmacy, and biological activity detection PK/PD 、QA/QC、 Registration application, clinical research and other departments.
The company has a research team led by Dr. Ding Qingjieke, a returned scientist, with 60 employees, including 10 doctors, 18 masters, and 36 employees with bachelor's degrees or above. Established chemical synthesis, process scaling up, pharmacy, and biological activity detection PK/PD 、QA/QC、 Registration application, clinical research and other departments. We are collaborating with Peking Union Medical College Hospital, Henan Cancer Medicine and other institutions to conduct Phase I clinical research.
Researchers
Bachelor's degree
Master's degree
Doctoral degree
PhD from Ocean University of China, professor at the School of Chemistry and Chemical Engineering, Henan Normal University, head of the Institute of Chemical Pharmaceutical Research, and director of the Henan Engineering Center. Formerly served as an external expert for national new drug evaluation, and has long been engaged in new drug research and development, as well as drug variety transformation
Ph.D. from Brown University and postdoctoral fellow at Georgetown University, former Senior Chief Scientist at Roche, with experience in launching one new drug and pushing six new drugs to different clinical stages. He is a talent under the "Hundred Talents Plan" of Henan Province and a specially appointed professor at Henan Normal University, engaged in the research and development of anti-tumor drugs for nearly 30 years.
PhD from Boston University, postdoctoral fellow at Harvard University, senior researcher, talent under the "Hundred Talents Program" in Hunan Province, specially appointed expert by the State Administration of Foreign Experts Affairs, and specially appointed professor at Hunan University. Engaged in biomedical research and management for nearly 30 years, leading and participating in the Sino US IND dual reporting of more than 10 new drugs. Led the team to successfully promote more than 10 innovative drugs to phase I-III clinical trials.
Doctor of Medicinal Chemistry from Nankai University, postdoctoral researcher in the Department of Chemistry at the University of Vermont, USA; once served as Director of the Medicinal Chemistry Department at Vertex Pharmaceuticals (USA) and Senior Scientist at Novartis Pharmaceuticals; specializing in innovative methods for finding new compounds, especially structure-based drug design, with over 30 years of experience in new drug development.
Doctor of Pharmacy from the University of North Carolina at Chapel Hill, USA, postdoctoral fellow at the National Institute of Statistical Sciences; an expert in computer-aided molecular structure design with nearly 20 years of experience in computational chemistry, covering virtual screening, molecular dynamics, and ADMET prediction.
Doctor of Medicine from Zhengzhou University;
once served as Senior Researcher at the University of Texas Southwestern Medical Center and Senior Researcher at the University of Alabama at Birmingham, USA.
He specializes in establishing animal disease models using gene editing technology and has extensive research experience in the fields of biochemistry, molecular biology, and pharmacy.
Specially appointed professor in Henan Province, enjoying special allowances from the State Council, expert in the key discipline of organic chemistry, academic leader, focusing on the design and synthesis of new drugs containing sugar, drug research and development, and research on new drug production processes.
• Outstanding Youth of Science and Technology Innovation in Henan Province, Academic and Technical Leader of Henan Provincial Department of Education
• Focusing on the research and development of innovative anti-tumor drugs, drug synthesis processes, and other fields
• Associate Professor at Henan Normal University, engaged in the design and synthesis of small molecule anti-tumor drugs, as well as the design and structural optimization of target based lead compounds
• Hosted multiple projects funded by the National Natural Science Foundation of China
Engaged in research and development of new anti-tumor drugs, as well as research on drug synthesis processes
PhD in Pharmaceutical Chemistry from East China University of Science and Technology, with 13 years of experience in new drug research and development
Obtained 1 FIC immunotherapy project IND for both China and the United States, and 1 Me too project IND
Ph.D. in Applied Chemistry from South China University of Technology, postdoctoral fellow at Sun Yat-sen University; with over 10 years of experience in organic synthesis, drug molecular design, screening and optimization research, as well as medicinal chemistry declaration.
Doctor of Medicine from Nanjing Medical University, with over 10 years of clinical medical research experience. Rich experience in FDA/CDE communication and exchange, as well as dual reporting between China and the United States;
Skilled in coordinating and communicating with clinical PIs and cross departmental teams
Master's degree from Beijing University of Chemical Technology, with over ten years of work experience in pharmaceutical research and development enterprises
Responsible for technical work such as drug screening and CMC research
Master's degree holder with experience in developing multiple innovative drug projects
Responsible for managing and tracking the entire process of toxicology and pharmacology experiments with CRO
Master's degree in microbiology from Henan Normal University. Currently, the director of the Microbial Pharmaceutical Enzyme and Cell Biology Detection Laboratory and am pursuing a PhD in biology.
Senior researcher at the Microbial Pharmaceutical Enzyme and Cell Biology Detection Laboratory, with a Master's degree in Biology.
With experience in multiple Phase I, II, and III clinical trial projects for innovative oncology drugs, responsible for the operational management of the company's clinical trials and the full-process management of CROs.
Master's degree holder, senior engineer, with 15 years of experience in new drug research and development. Participated in the research and development of new drugs such as Fruquintinib and Sofantinib at Hutchison MedPharmaceutical Company. Has 8 years of experience in pharmaceutical investment and financing, responsible for external relations and investment and financing work.
Years of experience in drug testing and quality control, responsible for establishing and ensuring the effective operation of the quality management system, cooperating with the drug regulatory department to inspect and ensure legality and compliance; Product registration declaration.
The QC director of the Microbial Pharmaceutical Analysis Laboratory and hold a Master's degree in Pharmaceutical Analysis from Jiangxi University of Traditional Chinese Medicine. I am engaged in research on drug quality analysis.
The director of the Microbial Medicine Pilot Scale Laboratory and hold a Master's degree in Organic Chemistry Synthesis of Drugs.
Researcher and master's degree holder at the Laboratory of Microbial Pharmaceutical Chemistry.
PCT/CN2020/089407
PCT/CN2020/133938
PCT/CN2021/106090
Address: Fengquan District Industrial Agglomeration Zone, Xinxiang City, Henan Province
Phone：0373-6358900 / 0373-6358801
Email：zwaybio@163.com
